{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:15:09Z","timestamp":1767989709251,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2000,8,31]],"date-time":"2000-08-31T00:00:00Z","timestamp":967680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,8,31]],"date-time":"2000-08-31T00:00:00Z","timestamp":967680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,9,1]]},"DOI":"10.1038\/sj.leu.2401872","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:37:20Z","timestamp":1031164640000},"page":"1634-1641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In vitro IL-12 treatment of peripheral blood mononuclear cells from patients with leukemia or myelodysplastic syndromes: increase in cytotoxicity and reduction in WT1 gene expression"],"prefix":"10.1038","volume":"14","author":[{"given":"L","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WJ","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Maksumova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Muratkhodjaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Shigeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JM","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HL","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,8,31]]},"reference":[{"key":"BF2401872_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.170.3.827","volume":"170","author":"M Kobayashi","year":"1989","unstructured":"Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G . Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes J Exp Med 1989 170: 827\u2013845","journal-title":"J Exp Med"},{"key":"BF2401872_CR2","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V84.12.4008.bloodjournal84124008","volume":"84","author":"G Trinchieri","year":"1994","unstructured":"Trinchieri G . Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes Blood 1994 84: 4008\u20134027","journal-title":"Blood"},{"key":"BF2401872_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1084\/jem.175.3.779","volume":"175","author":"MJ Robertson","year":"1992","unstructured":"Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH, Ritz J . Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF J Exp Med 1992 175: 779\u2013788","journal-title":"J Exp Med"},{"key":"BF2401872_CR4","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/blood.V82.9.2790.2790","volume":"82","author":"RJ Soiffer","year":"1993","unstructured":"Soiffer RJ, Robertson MJ, Murray C, Cochran K, Ritz J . Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematological and solid malignancies Blood 1993 82: 2790\u20132796","journal-title":"Blood"},{"key":"BF2401872_CR5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/sj.leu.2401085","volume":"12","author":"KC Stine","year":"1998","unstructured":"Stine KC, Warren BA, Becton DL . Interleukin-12 (IL-12) enhances lysis of non-lymphoid leukemia cell lines in vitro Leukemia 1998 12: 1204\u20131209","journal-title":"Leukemia"},{"key":"BF2401872_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-2141.1995.tb03375.x","volume":"90","author":"K Ogata","year":"1995","unstructured":"Ogata K, Tamura H, Yokose N, An E, Dan K, Hamaguchi H, Sakamaki H, Onozawa Y, Clark SC, Nomura T . Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromes Br J Haematol 1995 90: 15\u201321","journal-title":"Br J Haematol"},{"key":"BF2401872_CR7","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/sj.leu.2400813","volume":"11","author":"B Sarina","year":"1997","unstructured":"Sarina B, Cortelezzi A, Cattaneo C, Pomati M, Silvestris I, Di Stefano M, Lambertenghi-Deliliers D, Hu C, Monza M, Maiolo AT . In vitro effects of IL-12 and IL-2 on NK cells, cytokine release and clonogenic activity in myelodysplastic syndromes (MDS) Leukemia 1997 11: 1726\u20131731","journal-title":"Leukemia"},{"key":"BF2401872_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1084\/jem.179.4.1273","volume":"179","author":"R Manetti","year":"1994","unstructured":"Manetti R, Gerosa F, Giudizi MG, Biagiotti R, Parronchi P, Piccinni MP, Sampognaro S, Maggi E, Romagnani S, Trinchieri G . Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th 2 cell clones J Exp Med 1994 179: 1273\u20131283","journal-title":"J Exp Med"},{"key":"BF2401872_CR9","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.4049\/jimmunol.151.6.2943","volume":"151","author":"A Cesano","year":"1993","unstructured":"Cesano A, Visonneau S, Clark SC, Santoli D . Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12 J Immunol 1993 151: 2943\u20132957","journal-title":"J Immunol"},{"key":"BF2401872_CR10","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.4049\/jimmunol.149.12.3778","volume":"149","author":"MM Bertagnolli","year":"1992","unstructured":"Bertagnolli MM, Lin BY, Young D, Herrmann SH . IL-12 augments antigen-dependent proliferation of activated T lymphocytes J Immunol 1992 149: 3778\u20133783","journal-title":"J Immunol"},{"key":"BF2401872_CR11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1084\/jem.178.4.1223","volume":"178","author":"MJ Brunda","year":"1993","unstructured":"Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK . Antitumor and antimetastatic activity of interleukin 12 against murine tumors J Exp Med 1993 178: 1223\u20131230","journal-title":"J Exp Med"},{"key":"BF2401872_CR12","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.4049\/jimmunol.153.4.1697","volume":"153","author":"CL Nastala","year":"1994","unstructured":"Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ, Lotze T . Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production J Immunol 1994 153: 1697\u20131706","journal-title":"J Immunol"},{"key":"BF2401872_CR13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00053895","volume":"14","author":"DJ Verbik","year":"1996","unstructured":"Verbik DJ, Stinson WW, Brunda MJ, Kessinger A, Joshi SS . In vivo therapeutic effects of interleukin-12 against highly metastatic residual lymphoma Clin Exp Metastas 1996 14: 219\u2013229","journal-title":"Clin Exp Metastas"},{"key":"BF2401872_CR14","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/intimm\/7.7.1135","volume":"7","author":"JP Zou","year":"1995","unstructured":"Zou JP, Yamamoto N, Fujii T, Takenaka H, Kobayashi M, Herrmann SH, Wolf SF, Fujiwara H, Hamaoka T . Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells Int Immunol 1995 7: 1135\u20131145","journal-title":"Int Immunol"},{"key":"BF2401872_CR15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V94.3.902.415k23_902_908","volume":"94","author":"AH Rook","year":"1999","unstructured":"Rook AH, Wood GS, Yoo EK, Elenitsas R, Kao DM, Sherman ML, Witmer WK, Rockwell KA, Shane RB, Lessin SR, Vonderheid EC . Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses Blood 1999 94: 902\u2013908","journal-title":"Blood"},{"key":"BF2401872_CR16","unstructured":"Ohno R, Yamaguchi Y, Toge T, Kinouchi T, Kotake T, Shibata M, Kiyohara Y, Ikeda S, Fukui I, Gohchi A, Sugiyama Y, Saji S, Hazama S, Oka M, Ohhashi Y, Tsukagoshi S, and Taguchi T . Phase I and pharmacokinetic study of subcutaneous administered recombinant human interleukin 12 and its biological effects in patients with advanced malignancies Clin Cancer Res (in press)"},{"key":"BF2401872_CR17","first-page":"1183","volume":"4","author":"RJ Motzer","year":"1998","unstructured":"Motzer RJ, Rakhit A, Schwartz LH, Olencki T, Malone TM, Sandstrom K, Nadeau R, Parmar H, Bukowski R . Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma Clin Cancer Res 1998 4: 1183\u20131191","journal-title":"Clin Cancer Res"},{"key":"BF2401872_CR18","first-page":"3983","volume":"5","author":"JE Portielje","year":"1999","unstructured":"Portielje JE, Kruit WH, Schuler M, Beck J, Lamers CH, Stoter G, Huber C, de Boer-Dennert M, Rakhit A, Bolhuis RL, Aulitzky WE . Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer Clin Cancer Res 1999 5: 3983\u20133989","journal-title":"Clin Cancer Res"},{"key":"BF2401872_CR19","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","volume":"84","author":"K Inoue","year":"1994","unstructured":"Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Dohy H, Nakauchi H, Ishidate T, Akiyama T, Kishimoto T . WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia Blood 1994 84: 3071\u20133079","journal-title":"Blood"},{"key":"BF2401872_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/oxfordjournals.annonc.a059321","volume":"6","author":"J Brieger","year":"1995","unstructured":"Brieger J, Weidmann E, Maurer U, Hoelzer D, Mitrou PS, Bergmann L . The Wilms\u2019 tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR Ann Oncol 1995 6: 811\u2013816","journal-title":"Ann Oncol"},{"key":"BF2401872_CR21","first-page":"1060","volume":"9","author":"HD Menssen","year":"1995","unstructured":"Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwartz S, Reinhardt R, Thiel E . Presence of Wilms\u2019 tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias Leukemia 1995 9: 1060\u20131067","journal-title":"Leukemia"},{"key":"BF2401872_CR22","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood.V90.3.1217","volume":"90","author":"L Bergmann","year":"1997","unstructured":"Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, Hoelzer D . High levels of Wilms\u2019 tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome Blood 1997 90: 1217\u20131225","journal-title":"Blood"},{"key":"BF2401872_CR23","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1182\/blood.V88.6.2267.bloodjournal8862267","volume":"88","author":"K Inoue","year":"1996","unstructured":"Inoue K, Ogawa H, Yamagami T, Soma T, Tani Y, Tatekawa T, Oji Y, Tamaki H, Kyo T, Dohy H, Hiraoka A, Masaoka T, Kishimoto T, Sugiyama H . Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels Blood 1996 88: 2267\u20132278","journal-title":"Blood"},{"key":"BF2401872_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.leu.2401341","volume":"13","author":"H Tamaki","year":"1999","unstructured":"Tamaki H, Ogawa H, Ohyashiki K, Ohyashiki JH, Iwama H, Inoue K, Soma T, Oka Y, Tatekawa T, Oji Y, Tsuboi A, Kim EH, Kawakami M, Fuchigami K, Tomonaga M, Toyama K, Aozasa K, Kishimoto T, Sugiyama H . The Wilms\u2019 tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes Leukemia 1999 13: 393\u2013399","journal-title":"Leukemia"},{"key":"BF2401872_CR25","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood.V87.7.2878.bloodjournal8772878","volume":"87","author":"T Yamagami","year":"1996","unstructured":"Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, Kudoh T, Akiyama T, Murakami A, Maekawa T . Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis Blood 1996 87: 2878\u20132884","journal-title":"Blood"},{"key":"BF2401872_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0022-1759(93)90327-4","volume":"166","author":"L Chang","year":"1993","unstructured":"Chang L, Gusewitch GA, Chritton DB, Folz JC, Lebeck LK, Nehlsen-Cannarella SL . Rapid flow cytometric assay for the assessment of nature killer cell activity J Immunol Meth 1993 166: 45\u201354","journal-title":"J Immunol Meth"},{"key":"BF2401872_CR27","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1038\/sj.leu.2401213","volume":"12","author":"A Gaiger","year":"1998","unstructured":"Gaiger A, Schmid D, Heinze G, Linnerth B, Greinix H, Kalhs P, Tisljar K, Priglinger S, Laczika K, Mitterbauer M, Novak M, Mitterbauer G, Mannhalter C, Haas OA, Lechner K, Jager U . Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia Leukemia 1998 12: 1886\u20131894","journal-title":"Leukemia"},{"key":"BF2401872_CR28","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V89.4.1405","volume":"89","author":"K Inoue","year":"1997","unstructured":"Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, Oka Y, Miyake S, Tamaki H, Oji Y, Yamagami T, Tatekawa T, Soma T, Kishimoto T, Sugiyama H . Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia Blood 1997 89: 1405\u20131412","journal-title":"Blood"},{"key":"BF2401872_CR29","first-page":"2541","volume":"90","author":"JP Leonard","year":"1997","unstructured":"Leonard JP, Sherman ML, Fisher GL, Buchanan LJ, Larsen G, Atkins MB, Sosman JA, Dutcher JP, Vogelzang NJ, Ryan JL . Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production Blood 1997 90: 2541\u20132548","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401872.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401872","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401872.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T12:11:43Z","timestamp":1704283903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,31]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9,1]]}},"alternative-id":["BF2401872"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401872","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8,31]]},"assertion":[{"value":"12 January 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}